A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of—and repair ...

Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...

Abstract: This review delves into using e-learning technology and personalized recommendation systems in education. It examines 60 articles from prominent databases and identifies the different ...

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...

Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.

Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected ...

Baptist Health has become the first health system in the state of Arkansas to participate in a clinical trial to evaluate a new treatment for advanced heart failure.

Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19 ...

City-based Kauvery Hospital launched advanced electroanatomical mapping technology on Thursday for the treatment of complex heart rhythm disorders, including atrial fibrillation and ventricular ...

BrainSpace, a medtech focused on neurological injuries and illnesses, received 501 (k) clearance from the FDA for its brain ...

Introduction: The potassium voltage-gated channel Kv2.1 plays a crucial role in the development of the brain’s ventricular system. Defects in the development of this system affect the formation of the ...